Showing 261 - 280 results of 3,907 for search 'Owlpen~', query time: 3.59s Refine Results
  1. 261
  2. 262
  3. 263
  4. 264
  5. 265
  6. 266
  7. 267
  8. 268

    An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors by Russell J. Schilder, Drew Rasco, Manish R. Sharma

    Published 2025-03-01
    “…Methods: This phase 1, open-label, dose-finding study evaluated the maximum tolerated dose (MTD), safety, efficacy, and pharmacokinetics of ESK-440 in participants with advanced or metastatic solid tumors (ClinicalTrials.gov: NCT01922752). …”
    Get full text
    Article
  9. 269

    Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial by Run-Cong Nie, Shu-Qiang Yuan, Ya Ding, Yong-Ming Chen, Yuan-Fang Li, Cheng-Cai Liang, Mu-Yan Cai, Guo-Ming Chen, Wei Wang, Xiao-Wei Sun, De-Sheng Weng, Dan-Dan Li, Jing-Jing Zhao, Xiao-Jiang Chen, Yuan-Xiang Guan, Zhi-Min Liu, Yao Liang, Ma Luo, Jun Chi, Hai-Bo Qiu, Zhi-Wei Zhou, Xiao-Shi Zhang, Ying-Bo Chen

    Published 2025-02-01
    “…Abstract This prospective, nonrandomized, open-label phase 2 trial (Chinese Clinical Trial Registry, ChiCTR2200061906) aimed to evaluate the effectiveness of adding the PD-1 antibody tislelizumab to perioperative chemotherapy in patients with locally advanced gastroesophageal junction adenocarcinoma (GEJA). …”
    Get full text
    Article
  10. 270
  11. 271
  12. 272
  13. 273

    Evaluation of acute postoperative pain management after living donor nephrectomy during the transition from open access to laparoscopic and minimally invasive robotic surgical approach by Amer Majeed, Noon E. Abdelgadir, Areej A.G. AlFattani, Bilal Tufail, Muhammad Shabbir, Sajjad Rasool, Basel A. Jobeir

    Published 2025-01-01
    “…Background: Living donor nephrectomies (LDN) at our institution transitioned from open access to laparoscopic and, more recently, to a minimally invasive robotic surgical approach between 2019 and 2022. …”
    Get full text
    Article
  14. 274

    Comparative effectiveness of laparoscopic versus open colectomy in colon cancer patients: a study protocol for emulating a target trial using cancer registry data by Semaw Ferede Abera, Gabriele Robers, Anika Kästner, Ulrike Stentzel, Kerstin Weitmann, Wolfgang Hoffmann

    Published 2025-01-01
    “…Abstract Introduction: The objective of this study is to compare the 5 year overall survival of patients with stage I–III colon cancer treated by laparoscopic colectomy versus open colectomy. Methods: Using Mecklenburg-Western Pomerania Cancer Registry data from 2008 to 2018, we will emulate a phase III, multicenter, open-label, two-parallel-arm hypothetical target trial in adult patients with stage I–III colon cancer who received laparoscopic or open colectomy as an elective treatment. …”
    Get full text
    Article
  15. 275
  16. 276
  17. 277
  18. 278
  19. 279
  20. 280

    Dealing with post-excavation data: the Omeka S TiMMA web-database by Rueff, Bastien

    Published 2024-01-01
    Subjects: “…Omeka S, Web-based database, Open-science, Timber, Aegean prehistory…”
    Get full text
    Article